Lawton Alison Frances 4
4 · Aeglea BioTherapeutics, Inc. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 totalExercise: $6.80Exp: 2031-06-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.